ATH alterity therapeutics limited
Add to My Watchlist 66.7% ! 1.5¢

ad imagine trial, page-8

  1. maslow
    1,302 Posts.
    lightbulb Created with Sketch. 6
    clock Created with Sketch.
    18/03/14
    17:46
    Post #: 13142761
    Unmet clinical need is the main criteria which hopefully PBT2 will satisfy

    Fast track with orphan status for HD should get things moving nicely

    GLTAH

    The mouse is waiting to roar


    PBT Price at posting: $1.16 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Modelling Confirms Exceptional Heat Sink Performance for VHD Technology
right-arrow Created with Sketch.
NEWS Rincon Lithium Project to be powered by 40MW energy infrastructure
right-arrow Created with Sketch.
NEWS Johns Lyng Group enters scheme implementation deed with PEP
right-arrow Created with Sketch.
NUZ Positive FDA feedback on NUZ-001 strategy to lift clinical hold
right-arrow Created with Sketch.
HAR Maiden Drilling Program to Commence at Ibel South Gold Project
right-arrow Created with Sketch.
NEWS Significant gold intercepts below Samat and Sorowar pits in resource drilling update
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.5¢ 		Change
0.006(66.7%) 		Mkt cap ! $136.9M
Open High Low Value Volume
1.0¢ 1.5¢ 1.0¢ $1.185M 92.95M

Buyers (Bids)

No. Vol. Price($)
3 742856 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 4020492 17
View Market Depth
Last trade - 16.10pm 11/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.